Main Topic Area
All Topic Areas
1 - 10 of 84 more >>
Clinical Trials
1 - 2 of 2
- Phase III, Open, Comparative Study in Healthy Adults Aged 18-50 Years Administered With Hepatyrix or Havrix + Typherix or Tiphim Vi, to Compare Reactogenicity and Immunogenicity.
ClinicalTrials.gov Identifier: NCT00197249 - Active, not recruiting
Prophylaxis of Typhoid and Hepatitis A and B
- Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
ClinicalTrials.gov Identifier: NCT00139113 - Completed
Hepatitis A

Not Signed In -

